secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2023-05-17T23:59:59+00:00
Accession:  0001600620-23-000015
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia shareholders reject say-on-pay, equity plan; two directors resign after low support
--------------------------------------------------------------------------------

- Directors Milne and Hagan received less than majority support; resignations submitted per Majority Voting Policy; board to decide.
- Non-binding say-on-pay failed: 26.85M for, 42.75M against, plus 20.02M broker non-votes.
- Equity Incentive Plan amendment not approved: 30.71M for, 39.15M against, plus 20.02M broker non-votes.
- PricewaterhouseCoopers appointed auditor with 79.86M for, 6.86M against.
- All eight director nominees elected but Milne and Hagan had lower support; others had 40-44M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000160062023000015/0001600620-23-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000160062023000015/auph-20230517.htm
  HTML page:      https://secwatch.observer/filing/0001600620-23-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer